2005 - Current FRX Memantine Trials ....
Study ID: MEM-MD-03
Title: A Long-Term Extension Study Evaluating the Safety and Tolerability of Four Memantine Dosing Regimens in Patients with Moderate to Severe Dementia of the Alzheimer's Type
Start Date: 11-JUN-2003
Key Objective(s): To evaluate the long-term safety of memantine patients with moderate to severe dementia of the Alzheimer's type.
Recruitment: Closed
Study ID: MEM-MD-11
Title: A Long-Term Extension Study Evaluating the Safety and Tolerability of BID and QD Administration of Memantine in Patients with Mild to Moderate Dementia of the Alzheimer's Type
Start Date: 23-OCT-2003
Key Objective(s): To evaluate the long-term safety of memantine patients with mild to moderate dementia of the Alzheimer's type.
Recruitment: Closed
Study ID: MEM-MD-19
Title: A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study of the Efficacy and Safety of Memantine in Comparison to Gabapentin in Patients with Painful Diabetic Neuropathy
Start Date: 19-APR-2004
Key Objective(s): To compare the efficacy and safety of memantine to gabapentin and placebo in diabetic patients with painful neuropathy.
Recruitment: Closed
Study ID: MEM-MD-20
Title: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study of the Efficacy and Safety of Memantine in Comparison to Gabapentin in Patients with Postherpetic Neuralgia
Start Date: 19-APR-2004
Key Objective(s): To compare the efficacy and safety of memantine to gabapentin and placebo in patients with postherpetic neuralgia.
Recruitment: Open
Study ID: MEM-MD-22
Title: A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effectiveness and Safety of Memantine in Nursing Home Residents with Moderate to Severe Alzheimer's Disease
Start Date: 05-OCT-2004
Key Objective(s): To evaluate the effectiveness and safety of memantine compared to placebo in nursing home residents.
Recruitment: Open
Study ID: MEM-MD-23
Title: A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Non-Institutionalized Agitated Patients with Moderate to Severe Alzheimer's Disease
Start Date: 27-OCT-2004
Key Objective(s): To evaluate the safety and efficacy of memantine compared to placebo in non-institutionalized agitated patients with moderate to severe Alzheimer's disease.
Recruitment: Open
Study ID: MEM-MD-24
Title: A Pilot Evaluation of the Safety, Tolerability, Pharmacokinetics, and Efficacy of Memantine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder (ADHD) Combined Type
Start Date: 24-MAY-2004
Key Objective(s): To provide preliminary evaluations of the tolerability and safety of memantine in pediatric patients with ADHD combined type.
Recruitment: Closed
Study ID: MEM-MD-27
Title: A Pilot Evaluation of the Safety and Efficacy of Memantine in Patients with Acute Mania Associated with Bipolar I Disorder
Start Date: 09-FEB-2005
Key Objective(s): To evaluate the safety, tolerability and efficacy of open-label memantine monotherapy in the acute management of adults with Bipolar I disorder.
Recruitment: Open
Study ID: MEM-MD-29
Title: A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Persistent Residual Symptoms
Start Date: 01-JUL-2004
Key Objective(s): To evaluate the safety and efficacy of memantine as adjunctive treatment to atypical antipsychotic medications in schizophrenia patients who are residually symptomatic.
Recruitment: Open
|
